Regulation of interleukin-2 and interferon-gamma gene expression in renal failure.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1942774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant regulation of interleukin-2 but not of interferon-gamma gene expression in Down syndrome (trisomy 21).

  1991cited by this paper
• Regulation of Human Interleukin‐2 and Interferon‐Gamma Gene Expression by Suppressor T Lymphocytes

  1991cited by this paper
• Effect of renal replacement therapy on cellular cytokine production in patients with renal disease.

  1990cited by this paper
• Studies on T-cell colony formation in chronic renal failure (CRF) patients.

  1989cited by this paper
• In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients.

  1989cited by this paper
• Continuous ambulatory peritoneal dialysis.

  1988cited by this paper
• The immune status of the uremic patient: hemodialysis vs CAPD.

  1988cited by this paper
• Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy.

  1988cited by this paper
• Superinduction of the human gene encoding immune interferon.

  1987cited by this paper
• Evaluation of the in vitro production of interferon gamma and other lymphokines in uremic patients.

  1987cited by this paper
• In vivo anti‐tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN‐γ, on a syngeneic murine melanoma

  1986cited by this paper
• T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.

  1986cited by this paper
• Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.

  1986cited by this paper
• Isolation of an immunosuppressive fraction in ultrafiltrate from uremic sera.

  1985cited by this paper
• Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.

  1984cited by this paper
• Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor

  1984cited by this paper
• Superinduction of human interleukin-2 messenger RNA by inhibitors of translation.

  1984cited by this paper
• A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridization.

  1984cited by this paper
• Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

  1984cited by this paper
• Active hepatitis B vaccination of dialysis patients and medical staff.

  1984cited by this paper
• Continuous ambulatory peritoneal dialysis improves immunodeficiency in uremic patients.

  1983cited by this paper
• Structure and expression of a cloned cDNA for human interleukin-2

  1983cited by this paper
• T cell subsets and cellular immunity in end-stage renal disease.

  1983cited by this paper
• Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.

  1983cited by this paper
• Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and gamma-interferon.

  1982cited by this paper
• Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

  1982cited by this paper
• Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins.

  1982cited by this paper
• Activation of natural cytotoxicity of human peripheral blood mononuclear cells by interferon: a kinetic study and comparison of different interferon types

  1982cited by this paper
• Interleukin-2 augments natural killer cell activity

  1981cited by this paper
• Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA.

  1981cited by this paper
• Malignant diseases in patients treated by dialysis and transplantation in Europe.

  1981cited by this paper
• Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.

  1980cited by this paper
• Selective reconstitution of nude mice with long-term cultured and cloned specific helper T cells

  1980cited by this paper
• T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

  1980cited by this paper
• Host defenses and immunologic alterations associated with chronic hemodialysis.

  1980cited by this paper
• Interferon production by human and murine lymphocytes in response to alloantigens.

  1980cited by this paper
• Immunosuppressive effect of soluble E receptors in uremic serum.

  1979cited by this paper
• Studies on T lymphocyte activation I. Requirements for the mitogen‐dependent production of T cell growth factors

  1979cited by this paper
• Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis.

  1978cited by this paper
• T cell growth factor: parameters of production and a quantitative microassay for activity.

  1978cited by this paper
• Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with "middle molecules".

  1977cited by this paper
• T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.

  1975cited by this paper
• Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis.

  1972cited by this paper
• PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTS

  1957cited by this paper

• Subduing the Inflammatory Cytokine Storm

  2024cites this paper
• Impact of the interferon-γ release assay and glomerular filtration rate on the estimation of active tuberculosis risk before bronchoscopic examinations: a retrospective pilot study

  2020cites this paper
• Influence of hemodialysis on circulating CD4lowCD25high regulatory T cells in end-stage renal disease patients

  2013cites this paper
• Functional Mannose-Binding Lectin Levels in Patients with End-Stage Renal Disease on Maintenance Hemodialysis

  2012cites this paper
• Risk factors for herpes zoster reactivation in maintenance hemodialysis patients.

  2012cites this paper
• The influence of recombinant human erythropoietin on the immune system

  2009cites this paper
• [The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect].

  2008cites this paper
• Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients.

  2007cites this paper
• Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients

  2007cites this paper
• IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.

  2005cites this paper
• Influence of pretransplant dialysis modality on the change of lymphocyte subset populations and acute rejection rates after renal transplantation

  2004cites this paper
• Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure.

  2003cites this paper
• Anti-leukemic immunity against U937 cells in uremic patients.

  2003cites this paper
• A Switch to High-Flux Helixone® Membranes Reverses Suppressed Interferon-γ Production in Patients on Low-Flux Dialysis

  2003cites this paper
• Immunological basis of inflammation in dialysis.

  2002cites this paper
• Serum Levels of Soluble CD26 and CD30 in Patients on Hemodialysis

  2002cites this paper
• Ex vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma, and TNF-alpha in monocytes and T lymphocytes, in chronic hemodialysis patients.

  2000cites this paper
• Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?

  2000cites this paper
• Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients

  1999cites this paper
• Characteristic Cytokine Products of Th1 and Th2 Cells in Hemodialysis Patients

  1999cites this paper
• Hemodialysis-related lymphomononuclear release of interleukin-12 in patients with end-stage renal disease.

  1999cites this paper
• Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.

  1999cites this paper
• Cancer in End-Stage Renal Disease: Potential Factors Involved

  1998cites this paper
• Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD)

  1997cites this paper
• Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin.

  1997cites this paper
• Soluble and membrane bound IL-2 receptors (alpha and beta chains) in chronic hemodialyzed patients.

  1997cites this paper
• [Increased cancer incidence in terminal kidney failure: potential pathogenetic mechanisms].

  1997cites this paper
• Hyperinducible expression of the interferon‐gamma (IFN‐γ) gene and its suppression in systemic lupus erythematosus (SLE)

  1997cites this paper
• Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression.

  1996cites this paper
• Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.

  1996cites this paper
• T cells and B cells in chronic renal failure.

  1996cites this paper
• Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure.

  1995cites this paper
• The effects of the dialysis membrane on cytokine release.

  1994cites this paper
• Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis.

  1994cites this paper
• Profound reversible CD4+ T lymphocytopenia in a severely uremic patient.

  1994cites this paper
• Immune system dysregulation in uremia.

  1994cites this paper
• Parathyroid hormone dependent T cell proliferation in uremic rats.

  1993cites this paper
• T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway.

  1993cites this paper
• Effect of malnutrition and uremia on impaired cellular host defence.

  1992cites this paper